BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8451832)

  • 1. Protection of Pasteurella multocida dermonecrotic toxin-challenged rats by toxoid-induced antibody.
    Pettit RK; Rimler RB; Ackermann MR
    Vet Microbiol; 1993 Feb; 34(2):167-73. PubMed ID: 8451832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune responses of piglets to Pasteurella multocida toxin and toxoid.
    van Diemen PM; de Vries Reilingh G; Parmentier HK
    Vet Immunol Immunopathol; 1994 Jun; 41(3-4):307-21. PubMed ID: 7941310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization of rabbits against Pasteurella multocida using a commercial swine vaccine.
    Suckow MA
    Lab Anim; 2000 Oct; 34(4):403-8. PubMed ID: 11072861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological potency testing of vaccines against progressive atrophic rhinitis.
    Oppling V; Kusch M; Rübmann P; Cussler K
    Dev Biol Stand; 1996; 86():339. PubMed ID: 8785979
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of rats to compare atrophic rhinitis vaccines for protection against effects of heat-labile protein toxin produced by Pasteurella multocida serogroup D.
    Thurston JR; Rimler RB; Ackermann MR; Cheville NF
    Vet Immunol Immunopathol; 1992 Jun; 33(1-2):155-62. PubMed ID: 1632076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection by toxoid-induced antibody of gnotobiotic piglets challenged with the dermonecrotic toxin of Pasteurella multocida.
    Frymus T; Müller E; Franz B; Petzoldt K
    Zentralbl Veterinarmed B; 1989 Nov; 36(9):674-80. PubMed ID: 2532834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of a novel Pasteurella multocida vaccine against progressive atrophic rhinitis of swine.
    Hsuan SL; Liao CM; Huang C; Winton JR; Chen ZW; Lee WC; Liao JW; Chen TH; Chiou CJ; Yeh KS; Chien MS
    Vaccine; 2009 May; 27(22):2923-9. PubMed ID: 19428902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against progressive atrophic rhinitis by vaccination with Pasteurella multocida toxin purified by monoclonal antibodies.
    Foged NT; Nielsen JP; Jorsal SE
    Vet Rec; 1989 Jul; 125(1):7-11. PubMed ID: 2528856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of 4 truncated fragments of Pasteurella multocida toxin and their immunogenicity.
    Seo J; Pyo H; Lee S; Lee J; Kim T
    Can J Vet Res; 2009 Jul; 73(3):184-9. PubMed ID: 19794890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination against progressive atrophic rhinitis with a recombinant Pasteurella multocida toxin derivative.
    Nielsen JP; Foged NT; Sørensen V; Barfod K; Bording A; Petersen SK
    Can J Vet Res; 1991 Apr; 55(2):128-38. PubMed ID: 1832079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Bordetella bronchiseptica and serotype D Pasteurella multocida bacterin-toxoid on the occurrence of atrophic rhinitis after experimental infection with B. bronchiseptica and toxigenic type AP. multocida.
    Sakano T; Okada M; Taneda A; Mukai T; Sato S
    J Vet Med Sci; 1997 Jan; 59(1):55-7. PubMed ID: 9035080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect on the incidence of atrophic rhinitis of vaccination of sows with a vaccine containing Pasteurella multocida toxin.
    Pedersen KB; Barfod K
    Nord Vet Med; 1982; 34(7-9):293-302. PubMed ID: 7177813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of an atrophic rhinitis vaccine under controlled conditions.
    Voets MT; Klaassen CH; Charlier P; Wiseman A; Descamps J
    Vet Rec; 1992 Jun; 130(25):549-53. PubMed ID: 1496755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic study and optimization of Salmonella delivery strains expressing adhesin and toxin antigens for protection against progressive atrophic rhinitis in a murine model.
    Hur J; Byeon H; Lee JH
    Can J Vet Res; 2014 Oct; 78(4):297-303. PubMed ID: 25355999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of neutralizing antibodies against Pasteurella multocida toxin in swine with atrophic rhinitis].
    Bechmann G; Schöss P
    Dtsch Tierarztl Wochenschr; 1991 Aug; 98(8):310-2. PubMed ID: 1935682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of a truncated Pasteurella multocida toxin antigen in Bordetella bronchiseptica.
    Rajeev S; Nair RV; Kania SA; Bemis DA
    Vet Microbiol; 2003 Jul; 94(4):313-23. PubMed ID: 12829385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and efficacy of three recombinant subunit Pasteurella multocida toxin vaccines against progressive atrophic rhinitis in pigs.
    Liao CM; Huang C; Hsuan SL; Chen ZW; Lee WC; Liu CI; Winton JR; Chien MS
    Vaccine; 2006 Jan; 24(1):27-35. PubMed ID: 16122849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Method for quantifying the Pasteurella multocida antigen adsorbed on aluminum hydroxide adjuvant in swine atrophic rhinitis vaccine.
    Yoshimura M; Honda Y; Yonemitsu E; Kuraoka K; Suenaga K
    PLoS One; 2024; 19(5):e0301688. PubMed ID: 38768145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of an indirect enzyme-linked immunosorbent assay (ELISA) using recombinant toxin for detection of antibodies against Pasteurella multocida toxin.
    Takada-Iwao A; Uto T; Mukai T; Okada M; Futo S; Shibata I
    J Vet Med Sci; 2007 Jun; 69(6):581-6. PubMed ID: 17611352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the immunogenicity of formaldehyde detoxified Pasteurella multocida toxin.
    Bording A; Foged NT
    Vet Microbiol; 1991 Nov; 29(3-4):267-80. PubMed ID: 1771750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.